Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 07 Jun 2024 22:45:36 +0200Tue, 30 Apr 2024 13:03:00 +0200Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kisplyxHuman medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/kisplyxTue, 30 Apr 2024 13:03:00 +0200Human medicineKisplyx : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500216286_en.pdfKisplyx : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500216286_en.pdfWed, 16 Nov 2016 12:06:00 +0100Human medicine